Charles River Laboratories 2Q10 2Q Revenues: $292 million (-5%) 2Q Earnings: $15 million (-57%) YTD Revenues: $589 million (-3%) YTD Earnings: $31 million (-46%) Comments: The Research Models and Services (RMS) unit was flat at $166 million for the quarter. Gains from in vitro products were offset by lower sales of large models. The Preclinical Services (PCS) business saw revenues drop 12% to $125 million in 2Q10, driven by lower prices and reduced demand. The PCS unit reported mo...